stock price
Barclays Downgrades Illumina to Underweight
In Monday morning trading on the Nasdaq, shares of Illumina were down 7 percent at $103.65.
GeneDx Shares Fall on Short Seller Report
Several Wall Street analysts took issue with the short seller's report, calling the claims false and unrelated to GeneDx's current operations.
GenomeWeb Top 40 Rises 10 Percent in January, Outpacing Gains in Broader Market
The Dow Jones Industrial Average rose 5 percent while the Nasdaq rose 2 percent, and the Nasdaq Biotech Index rose 5 percent.
Quanterix to Acquire Akoya Biosciences
The deal will integrate Akoya's spatial biology capabilities with Quanterix's biomarker-detection tools for ultra-sensitive detection of protein biomarkers in blood and tissue.
GenomeWeb Top 40 Drops 3 Percent in 2024, Reflecting Larger Life Science Struggles in Stock Market
The Dow Jones Industrial Average rose 13 percent year over year, and the Nasdaq rose 29 percent, but the Nasdaq Biotech Index declined 1 percent.
Nov 25, 2024
Quantum-Si Laying off 23 Percent of Workforce
Jun 24, 2024
Illumina Completes Grail Divestment
May 1, 2024